Abeona Therapeutics Hosts Conference Call and Webcast

Abeona Therapeutics ( (ABEO) ) has provided an update.

On April 29, 2025, Abeona Therapeutics Inc. hosted a conference call and webcast, providing a presentation that was furnished as Exhibit 99.1 to a Current Report on Form 8-K. The company clarified that the information shared is not considered ‘filed’ under the Securities Exchange Act of 1934 unless explicitly stated in future filings.

Spark’s Take on ABEO Stock

According to Spark, TipRanks’ AI Analyst, ABEO is a Neutral.

Abeona Therapeutics faces substantial financial hurdles with negative cash flows and no revenue growth. The potential for FDA approval and high revenue from pz-cel offer a positive outlook, yet initial supply constraints and increased expenses present risks. Technical analysis indicates limited momentum, and the negative valuation metrics reflect challenges typical for a biotech at this stage.

To see Spark’s full report on ABEO stock, click here.

More about Abeona Therapeutics

YTD Price Performance: -9.48%

Average Trading Volume: 601,162

Technical Sentiment Signal: Buy

Current Market Cap: $261.1M

For an in-depth examination of ABEO stock, go to TipRanks’ Stock Analysis page.